Assessment and Diagnostic Classification Using DC:0-5 in Early Childhood Mental Health Clinics: The Protocol for the Developmental Psychiatry Diagnostic Challenges Study (DePsy)
- PMID: 38002860
- PMCID: PMC10670515
- DOI: 10.3390/children10111770
Assessment and Diagnostic Classification Using DC:0-5 in Early Childhood Mental Health Clinics: The Protocol for the Developmental Psychiatry Diagnostic Challenges Study (DePsy)
Abstract
Mental health problems in early childhood are common, but there is a lack of psychiatric research on this age group. DC:0-5 is a multiaxial classification system for mental disorders in early childhood, providing a framework for standardizing clinical practice and research. However, research on the validity of DC:0-5 is scarce. The Developmental Psychiatry Diagnostic Challenges Study (DePsy) is a multi-site, prospective clinical study including six German early childhood mental health (ECMH) clinics. The main objective of the study is to contribute to the validation of Axis I and Axis II of DC:0-5. A second aim of the study is to describe the population of the participating clinics regarding diagnoses, family context, and treatment outcomes. Additionally, the impact of environmental risk factors, including parental Adverse Childhood Experiences (ACEs) and media use, on child psychopathology and caregiver-child relationships will be examined. Over two years, patients aged 0.0-5.9 years old will be enrolled in the study. Assessments include ICD-10 and DC:0-5 diagnoses, developmental tests, video-based observations of caregiver-child interactions, and questionnaires on child psychopathology, media use, parental stress, and treatment satisfaction. Study results will promote the standardization of assessment and treatment in ECMH clinics aiming to improve the development of patients and their families.
Keywords: DC:0-5; child psychiatry; early childhood.
Conflict of interest statement
C.U.C. has been a consultant and/or advisor to, or has received honoraria from, AbbVie, Acadia, Alkermes, Allergan, Angelini, Aristo, Biogen, Boehringer-Ingelheim, Cardio Diagnostics, Cerevel, CNX Therapeutics, Compass Pathways, Darnitsa, Denovo, Gedeon Richter, Hikma, Holmusk, IntraCellular Therapies, Jamjoom Pharma, Janssen/J&J, Karuna, LB Pharma, Lundbeck, MedAvante-ProPhase, MedInCell, Merck, Mindpax, Mitsubishi Tanabe Pharma, Mylan, Neurocrine, Neurelis, Newron, Noven, Novo Nordisk, Otsuka, Pharmabrain, PPD Biotech, Recordati, Relmada, Reviva, Rovi, Sage, Seqirus, SK Life Science, Sumitomo Pharma America, Sunovion, Sun Pharma, Supernus, Takeda, Teva, Tolmar, Vertex, and Viatris. He provided expert testimony for Janssen and Otsuka. He served on Data Safety Monitoring Boards for Compass Pathways, Denovo, Lundbeck, Relmada, Reviva, Rovi, Supernus, and Teva. He has received grant support from Janssen and Takeda. He has received royalties from UpToDate and is also a stock option holder of Cardio Diagnostics, Kuleon Biosciences, LB Pharma, Mindpax, and Quantic. The other authors have nothing to declare.
Similar articles
-
Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.Turk Psikiyatri Derg. 2021;32(4):293-295. doi: 10.5080/u26899. Turk Psikiyatri Derg. 2021. PMID: 34964106 English, Turkish.
-
DC: 0-5 system in clinical assessment with specialty pediatric populations.Infant Ment Health J. 2023 May;44(3):372-386. doi: 10.1002/imhj.22034. Epub 2023 Mar 1. Infant Ment Health J. 2023. PMID: 36857410
-
DEFINING RELATIONAL PATHOLOGY IN EARLY CHILDHOOD: THE DIAGNOSTIC CLASSIFICATION OF MENTAL HEALTH AND DEVELOPMENTAL DISORDERS OF INFANCY AND EARLY CHILDHOOD DC:0-5 APPROACH.Infant Ment Health J. 2016 Sep;37(5):509-20. doi: 10.1002/imhj.21590. Epub 2016 Aug 30. Infant Ment Health J. 2016. PMID: 27574772 Review.
-
Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.Med J Aust. 2019 Nov;211 Suppl 9:S3-S46. doi: 10.5694/mja2.50383. Med J Aust. 2019. PMID: 31679171
-
[Diagnostic structured interviews in child and adolescent's psychiatry].Encephale. 2004 Mar-Apr;30(2):122-34. doi: 10.1016/s0013-7006(04)95422-x. Encephale. 2004. PMID: 15107714 Review. French.
Cited by
-
Assessment of affective dysregulation in children: development and evaluation of a semi-structured interview for parents and for children.Child Adolesc Psychiatry Ment Health. 2024 Jun 20;18(1):75. doi: 10.1186/s13034-024-00762-8. Child Adolesc Psychiatry Ment Health. 2024. PMID: 38902809 Free PMC article.
-
Familial context influences media usage in 0- to 4-year old children.Front Public Health. 2024 Jan 11;11:1256287. doi: 10.3389/fpubh.2023.1256287. eCollection 2023. Front Public Health. 2024. PMID: 38274543 Free PMC article.
References
-
- Skovgaard A.M., Houmann T., Christiansen E., Landorph S., Jørgensen T., CCC 2000 Study Team. Olsen E., Heering K., Kaas-Nielsen S., Samberg V., et al. The Prevalence of Mental Health Problems in Children 1½ Years of Age—The Copenhagen Child Cohort 2000. J. Child Psychol. Psychiatry. 2007;48:62–70. doi: 10.1111/j.1469-7610.2006.01659.x. - DOI - PubMed
-
- Zero to Three . Diagnostic Classification of Mental Health & Developmental Disorders of Infancy and Early Childhood (DC: 0-3) ZERO TO THREE/National Center for Clinical Infant Programs; Washington, DC, USA: 1994.
LinkOut - more resources
Full Text Sources